Contract awardedPCR and molecular diagnostic platforms

Chrystal Medical supplies C. difficile tests to Mersey and West Lancashire

Mersey and West Lancashire Teaching Hospitals NHS Trust buys gastro panel and C. difficile tests from Chrystal Medical Limited. The contract also covers upkeep of the EntericBio Realtime PCR laboratory equipment, which is due to be replaced in the second or third year.

The trust ordered the tests and maintenance through the East of England NHS Collaborative Procurement Hub framework. The five-year contract is worth £1,892,741 excluding VAT and runs from November 2025 to October 2030.

Alert me to similar tenders

Contract ends October 2030

What
PCR and molecular diagnostic platforms
Value
£1.89m
How it was bought
Call-off from a framework agreement
Dates and next
Nov 2025 to Oct 2030

How it was bought

1 official notice
  1. 1 Nov 2025Contract starts
  2. 5 Nov 2025Award noticeContracts Finder
  3. 30 Oct 2030Contract ends

How it compares

With every PCR and molecular diagnostic platforms award since 2021

Half of awards fall between £32,886 and £403,658Median £97,406

Awards
496
Firms that won them
82
Median award
£97,406
of 488 with a value
This award
Bigger than 90%
of them
Typical length
1 year
In North West
12 awards

Chrystal Medical Limited ranks 43rd of 82 firms for PCR and molecular diagnostic platforms awards since 2021.

RankFirmAwardsValue
1Locked103£31.8m
2Locked50£13.5m
3Locked45£97m
4Locked33£1.94m
5Locked24£105.1m
5Locked24£1.41m
43Chrystal Medical Limited Won this one1£1.89m
See who wins this work

Figures to 21 November 2026

PCR and molecular diagnostic platforms at other buyers

Mersey and West Lancashire Teaching Hospitals NHS Trust has awarded 402 contracts since 2021.

See Mersey and West Lancashire Teaching Hospitals NHS Trust's page
  • Chrystal Medical Limited has won 8 public contracts since 2021.

2 PCR and molecular diagnostic platforms tenders are open now

See them
More PCR and molecular diagnostic platforms contracts awarded in 2025